You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Details for Patent: 6,645,963


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,645,963
Title: Prolonged-action eye drop
Abstract:Eye drops containing a .beta.-blocker such as cartelol hydrochloride are improved in the penetration of the .beta.-blocker into the eye and the retention thereof in the eye tissues by the incorporation of a C.sub.3-7 fatty acid such as sorbic acid to the eye preparations.
Inventor(s): Higashiyama; Masayo (Kobe, JP), Ohtori; Akira (Kobe, JP)
Assignee: Senju Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:09/802,849
Patent Claim Types:
see list of patent claims
Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,645,963

Introduction

United States Patent 6,645,963, titled "Ophthalmic composition," is a patent that discloses a specific type of eye drop formulation. To understand the scope and claims of this patent, it is essential to delve into its details, the patent landscape, and the tools available for patent analysis.

Patent Overview

Patent Title and Number

  • The patent in question is titled "Ophthalmic composition" and bears the number 6,645,963.

Invention Description

  • This patent describes an ophthalmic composition, specifically an eye drop formulation that does not include a gelling component and provides a slow release of the active medicine[2].

Claims Analysis

Understanding Patent Claims

  • Patent claims are the legal definitions of what the inventor considers to be their invention. They define the scope of protection granted by the patent.

Claims of US Patent 6,645,963

  • The claims of this patent would typically include specific descriptions of the ophthalmic composition, such as the ingredients, their proportions, and the method of preparation. For example, the claims might specify the types of active ingredients, the absence of gelling components, and the mechanism of slow release.

Scope of the Patent

Patent Scope and Protection

  • The scope of a patent is determined by its claims. In the case of US Patent 6,645,963, the scope would cover any ophthalmic composition that matches the described formulation and functionality.

Limitations and Boundaries

  • The scope is limited by the specific claims made. For instance, any eye drop formulation that includes a gelling component or does not provide a slow release of the active medicine would not infringe on this patent.

Patent Landscape

Prior Art and Related Patents

  • To understand the patent landscape, one must search for prior art and related patents. Tools like the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) can be used to identify similar patents and citations[1].

Global Dossier and CCD

  • The Global Dossier allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. The CCD consolidates prior art cited by all participating offices, providing a comprehensive view of the patent family[1].

Search and Analysis Tools

USPTO Resources

  • The USPTO provides several resources for searching and analyzing patents, including the Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest. This tool offers enhanced access to prior art and modern interfaces for improved searching[1].

Patent and Trademark Resource Centers (PTRCs)

  • Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for detailed analysis[1].

Economic and Statistical Analysis

Patent Claims Research Dataset

  • The USPTO's Patent Claims Research Dataset can provide insights into patent scope and claims trends. This dataset includes detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014[3].

International Considerations

International Patent Offices

  • To ensure global protection, it is crucial to search for similar patents in international databases such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Practical Applications and Impact

Industry Impact

  • Patents like US 6,645,963 can significantly impact the pharmaceutical and ophthalmic industries by protecting innovative formulations and encouraging further research and development.

Competitive Landscape

  • Understanding the patent landscape helps companies navigate the competitive environment, avoid infringement, and identify opportunities for innovation.

Legal and Regulatory Aspects

Patent Enforcement and Litigation

  • The scope and claims of a patent are critical in patent enforcement and litigation. Accurate analysis of these elements can determine the outcome of legal disputes.

Regulatory Compliance

  • Compliance with regulatory requirements, such as those set by the FDA, is also essential. The patent must align with regulatory standards for ophthalmic compositions.

Conclusion

Analyzing the scope and claims of US Patent 6,645,963 involves a thorough examination of the patent's details, the broader patent landscape, and the use of various search and analysis tools. This analysis is crucial for understanding the protection granted by the patent, navigating the competitive landscape, and ensuring compliance with legal and regulatory requirements.

Key Takeaways

  • Patent Claims: Define the scope of protection and are critical for understanding what is protected.
  • Patent Landscape: Includes prior art, related patents, and international considerations.
  • Search Tools: USPTO resources like Patent Public Search, Global Dossier, and CCD are essential for comprehensive analysis.
  • Economic Analysis: Datasets like the Patent Claims Research Dataset provide valuable insights into patent trends.
  • International Considerations: Searching international databases is necessary for global protection.
  • Legal and Regulatory Aspects: Accurate analysis of scope and claims is vital for enforcement, litigation, and compliance.

FAQs

Q: What is the main invention described in US Patent 6,645,963? A: The main invention is an ophthalmic composition, specifically an eye drop formulation without a gelling component that provides a slow release of the active medicine.

Q: How can I search for related patents to US 6,645,963? A: Use tools like the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) to identify related patents and prior art.

Q: What is the significance of the Patent Claims Research Dataset? A: This dataset provides detailed information on claims from US patents and applications, offering insights into patent scope and trends.

Q: Why is it important to search international patent databases? A: Searching international databases ensures global protection and helps avoid infringement in other countries.

Q: How do patent claims impact the competitive landscape? A: Accurate analysis of patent claims helps companies navigate the competitive environment, avoid infringement, and identify innovation opportunities.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - CN101977630B: https://patents.google.com/patent/CN101977630B/en
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto
  5. Patent Docs - September 29, 2013 - October 5, 2013: https://www.patentdocs.org/2013/week40/

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,645,963

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 6,645,963

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan9-302802Nov 05, 1997
Japan10-250009Sep 03, 1998

International Family Members for US Patent 6,645,963

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Canada 2307303 ⤷  Try for Free
China 1124842 ⤷  Try for Free
China 1278162 ⤷  Try for Free
European Patent Office 1029537 ⤷  Try for Free
Germany 69839152 ⤷  Try for Free
Japan 4377052 ⤷  Try for Free
Spain 2297894 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.